Cynthia Arbeeny

Cynthia Arbeeny

Company: Mitotherapeutix

Job title: Chief Scientific Officer

Seminars:

C-Suite Discussion: Investigating Non-Conventional Approaches & Mechanisms of Actions to Address NASH: Spotlight on Gene Therapy, Mitochondria Based Therapeutics (MBTs), Regenerative Medicine, & RNA Therapeutics 1:00 pm

• How to apply lessons learned from the application of gene therapy tools for rare diseases to strategize a novel approach to NASH treatment • Investigating how mitochondria based therapeutics (MBTs) provide a differentiated mechanism of action to treat NASH patients • Understanding how to utilize regenerative medicine to systematically address critical challenges in NASH…Read more

day: Day 2 Stream 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.